InnoModels Biotechnology (Beijing) Co., Ltd_PDX_CDX_FACS

Cn / En

InnoModels

Provide top-quality preclinical services to pharmaceutical enterprises and translational research institutions

InnoModels

Have an experienced and high-performing management and research team

InnoModels

Focus on the development and application of oncology and Immun-oncology models

InnoModels

Combine innovative preclinical technology and unrivaled expertise to enable more efficient drug discovery and development





咨询电话 15010000264
售后服务
咨询电话 13810723384
返回顶部

R&D Service Platform

Humanized mice for l/O

iHuPBMC-T ， iHuPBMC-NK，iHuPBMC-B， iHuPBMC-Donor screening and QC, iHuPBMC-OncVax medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models.

Oncology in vivo

CDX models，iHuPDX models，

Orthotopic models，

Orthotopic mouse brain models...

in vitro cytotoxicity test

Patient-derived tumor cell screening, 3D orgnoid, IC50, Immunue cells mediated tumor killing assays immunotherapy to provide close to the clinical trials of a new generation of animal models.

Syngeneic models for l/O

Syngeneic models,

NK function assay in SCID mice, Genetically engineered mouse models

Cancer vaccine evaluation

Syngeneic-OncVax for cancer vaccine, MHC humanized mouse

Cell therapy

Car-T,Car-NK,

Car-T in MHC/KO mice,

Host vs graft (HVG)

in vitro immune assay

ELISpot,

ELISA,

FACS, qPCR

Non-GLP tox

GVHD experimental platform，

Immunogenicity Testing

PDX model

Lymphoma (LY),Chronic myeloproliferitve neoplasm (CMP), Myelodisplasic syndrome (MDS)

CDX model

Eosinophilia (EOS), Leukemia (LK), Myeloma (MYMA), Mastocytosis (MAS), Musculoskeletal and vascular systems (MSKV)

Homologous model

Nervous system (NS),Urinary system (US),Endocrine System (ES),

Female reproductory system (FRS)...

Database

【Database 1】

【Database 2】

InnoModels News

InnoModels has a stable immune system humanized mouse model platform (HIS) and a human tumor allotransplantation platform (PDX) in China.

News and Events

InnoModels always adhere to the quality of development, quality of survival principle, to promote the company to the development of collectivized economy

Company News

InnoModels Biotechnology IC50 Cell Activity Assay Platform

07 05

News and Events

InnoModels Biotechnology IC50 Cell Activity Assay Platform

As an important tool for biomedical research, the IC50 cell activity assay platform of InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful technical support for drug discovery, disease mechanism research and other fields. With its rich experience in drug discovery and development, advanced experimental technology and extensive cooperative network, the platform provides researchers with efficient, accurate and reliable cell activity assay services.

07 05

News and Events

InnoModels Biotechnology：3D Organoid Platform Features

In the field of biomedicine, we have been searching for a technology that can better mimic the structure and physiological functions of complex organs in the human body. This quest has been dramatically demonstrated in the 3D organoid platform from InnoModels Biotechnology. With its unique advantages, this platform is gradually leading a new trend in biomedical research.

06 05

News and Events

InnoModels Biotechnology iHuPDX Model: A New Milestone in Personalized Medicine

With the deepening of medical research, traditional cancer research and treatment methods can no longer meet the growing demand for individualization. Against this backdrop, the iHuPDX (Individualized Human Patient-Derived Xenograft) model of InnoModels Biotechnology has emerged, bringing a new perspective and solution to the field of cancer research and treatment.

30 04

News and Events

InnoModels Biotechnology: What are the features of the CDX modeling platform

InnoModels Biotechnology, an innovative company dedicated to advancing biomedical research and clinical therapeutics, provides powerful support for cancer research and drug development through its CDX (Cancer-Derived Xenograft) modeling platform. The platform is not only rich in experimental capabilities, but also has the unique advantage of providing scientists with efficient and precise tools to study the biology of cancer and its application in therapeutic areas in depth.





MORE

About InnoModels

InnoModels Biotechnology (Beijing) Co., Ltd. aims to serve new drug research and development enterprises, translational medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models

InnoModels Biotechnology (Beijing) Co., Ltd. aims to serve new drug research and development enterprises, translational medicine research institutions and cancer patients with innovative experimental animal models and in vitro research models. Gen die creature has domestic stability of the humanized mice immune system model (ihs) platform, and anthropogenic tumor allografts platform (symbol), focusing on tumor and tumor immune pharmacodynamics CRO services, translational medicine research service, individualized medicine, service transformation of new drug research and development enterprise, medical researchers, cancer patients, is dedicated to the research and development of tumor and tumor immunotherapy to provide close to the clinical trials of a new generation of animal models.

MORE

InnoModels Biotechnology (Beijing) Co., Ltd

TEL：15010000264 13810723384

Email：cndw@imodels.tech

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company